The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Interstitial dendritic cell guidance by haptotactic chemokine gradients
Weber, M., Hauschild, R., Schwarz, J., Moussion, C., de Vries, I., Legler, D. F., Luther, S. A., Bollenbach, T., & Sixt, M. (2013) · Science · doi:10.1126/science.1228456 · Cited by 555
Adoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
Modulation of hematopoietic stem cell homing and engraftment by CD26
Christopherson, K. W., Hangoc, G., Mantel, C. R., & Broxmeyer, H. E. (2004) · Science · doi:10.1126/science.1097071 · Cited by 452
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Puré, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38988 · Cited by 428
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Fridman, W. H., Galon, J., Pagès, F., Tartour, E., Sautès-Fridman, C., & Kroemer, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1316 · Cited by 380
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Kerkar, S. P., & Restifo, N. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4094 · Cited by 370
Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., & Norcross, M. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1865 · Cited by 332
The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3
Loetscher, P., Pellegrino, A., Gong, J.-H., Mattioli, I., Loetscher, M., Bardi, G., Baggiolini, M., & Clark-Lewis, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005652200 · Cited by 316
Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., & Polverini, P. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 287
Lambeir, A.-M., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Scharpé, S., Van Damme, J., & De Meester, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103106200 · Cited by 271
Durinx, C., Lambeir, A., Bosmans, E., Falmagne, J., Berghmans, R., Haemers, A., Scharpé, S., & De Meester, I. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01634.x · Cited by 267
Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A.-M., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3554 · Cited by 237
Pashenkov, M., Goëss, G., Wagner, C., Hörmann, M., Jandl, T., Moser, A., Britten, C. M., Smolle, J., Koller, S., Mauch, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9129 · Cited by 210
Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Casrouge, A., Decalf, J., Ahloulay, M., Lababidi, C., Mansour, H., Vallet-Pichard, A., Mallet, V., Mottez, E., Mapes, J., Fontanet, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci40594 · Cited by 189
Self-citationCpG Still Rocks! Update on an Accidental Drug
Krieg, A. M. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 187
Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells
Christopherson, K. W., Cooper, S., & Broxmeyer, H. E. (2003) · Blood · doi:10.1182/blood-2002-12-3893 · Cited by 171
Lee, J., Fassnacht, M., Nair, S., Boczkowski, D., & Gilboa, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2805 · Cited by 159
Ou, X., O’Leary, H. A., & Broxmeyer, H. E. (2013) · Blood · doi:10.1182/blood-2013-02-487470 · Cited by 146
Bonecchi, R., Locati, M., Galliera, E., Vulcano, M., Sironi, M., Fra, A., Gobbi, M., Vecchi, A., Sozzani, S., Haribabu, B., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4972 · Cited by 138
Loos, T., Mortier, A., Gouwy, M., Ronsse, I., Put, W., Lenaerts, J., Damme, J. V., & Proost, P. (2008) · Blood · doi:10.1182/blood-2008-04-149039 · Cited by 138
Safety of dipeptidyl peptidase 4 inhibitors: a perspective review
Karagiannis, T., Boura, P., & Τσάπας, Α. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614523031 · Cited by 137
Forssmann, U., Stoetzer, C., Stephan, M., Kruschinski, C., Skripuletz, T., Schade, J., Schmiedl, A., Pabst, R., Wagner, L., Hoffmann, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1120 · Cited by 123
Budhu, S., Loike, J. D., Pandolfi, A., Han, S. J., Catalano, G., Constantinescu, A., Clynes, R., & Silverstein, S. C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091279 · Cited by 123
Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase
den Steen, P. E. V., Husson, S. J., Proost, P., Damme, J. V., & Opdenakker, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.098 · Cited by 118
Overview of the mechanisms regulating chemokine activity and availability
Mortier, A., Damme, J. V., & Proost, P. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.015 · Cited by 113
Effect of posttranslational processing on the in vitro and in vivo activity of chemokines
Mortier, A., Gouwy, M., Damme, J. V., & Proost, P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.016 · Cited by 111
T Cell Receptor Gene Therapy for Cancer
Schmitt, T. M., Ragnarsson, G. B., & Greenberg, P. D. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.146 · Cited by 99
Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs
Bongers, J., LAMBROS, T. J., Ahmad, M., & Heimer, E. P. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90317-7 · Cited by 94
Carbone, A., Gloghini, A., Zagonel, V., Aldinucci, D., Gattei, V., Degan, M., Improta, S., Sorio, R., Monfardini, S., & Pinto, A. (1995) · Blood · doi:10.1182/blood.v86.12.4617.bloodjournal86124617 · Cited by 91
Mortier, A., Loos, T., Gouwy, M., Ronsse, I., Damme, J. V., & Proost, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119388 · Cited by 58
Riva, A., Laird, M. E., Casrouge, A., Ambrozaitis, A., Williams, R. L., Naoumov, N. V., Albert, M. L., & Chokshi, S. (2014) · Hepatology · doi:10.1002/hep.27139 · Cited by 53
Self-citationKajiyama, H., Kikkawa, F., Maeda, O., et al. (2002) · Oncology · doi:10.1159/000063801 · Cited by 51
In vivo regulation of chemokine activity by post‐translational modification
Moelants, E. A. V., Mortier, A., Damme, J. V., & Proost, P. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.16 · Cited by 50
Arwert, E. N., Mentink, R. A., Driskell, R. R., Hoste, E., Goldie, S. J., Quist, S., & Watt, F. M. (2011) · Oncogene · doi:10.1038/onc.2011.298 · Cited by 38
Ehlert, J. E., Gerdes, J., Flad, H., & Brandt, E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4975 · Cited by 33
Ehlert, J. E., Gerdes, J., Flad, H. ‐., et al. (1998) · PubMed · Cited by 31
Ragab, D., Laird, M. E., Duffy, D., Casrouge, A., Mamdouh, R., Abass, A., ElShennawy, D. E.-S., Shebl, A. M., Elkashef, W. F., Zalata, K. R., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.016 · Cited by 26
Self-citationIn vivo processing of CXCL12α/SDF‐1α after intravenous and subcutaneous administration to mice
Antonsson, B. E., de Lys, P., Dechavanne, V., Chevalet, L., & Boschert, U. (2010) · PROTEOMICS · doi:10.1002/pmic.201000331 · Cited by 15
Cited by
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Pitt, J. M., Vétizou, M., Daillère, R., Roberti, M. P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I. G., Chamaillard, M., Kroemer, G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.001 · Cited by 1,041
Metadata
- Authors
- Barreira da Silva, R., Laird, M. E., Yatim, N., Fiette, L., Ingersoll, M. A., & Albert, M. L.
- Venue
- Nature Immunology
- Published
- 2015-06-15
- Volume
- 16
- Issue
- 8
- Pages
- 850-858
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W4242141803
- Cited by
- 337
- References
- 48
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.